PATENT CLAIM ANALYSIS

Application Number: 15928066
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "011000"]

Abstract:
This invention relates to a method for assessing risk of Coronary Vascular Disease (CVD). Specifically, it relates to utilizing risk assessment from both Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) in combination. In addition the invention relates to a method for assessing risk of Coronary Vascular Disease (CVD) in a patient with low to normal Low Density Lipoprotein Cholesterol (LDL) levels utilizing both LDL and Lipoprotein Associated Phospholipase A2 (Lp-PLA2). Moreover, the invention relates to the use of risk associated with Lp-PLA2, CRP and LDL in combination and specific ranges thereof to predict Coronary Vascular Disease.

Claim (Index 29):
The method of  claim 24 , wherein the patient's risk of CVD is determined by using the Adult Treatment Panel III (ATP III) guidelines.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 2.16667
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12465930', '13063303', '13416014', '14154074', '14153994']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6842980647564585
- 35 USC 102 Novelty (BERT): 0.556576421840581
- Combined Prediction Score: 0.6715259004648708
- Mean Citation Score: 361.783094
- Max Citation Score: 375.3696
- Similarity Product: 248.8162759729385

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test